BRIEF-Imugene Says Cohort Review Committee Confirmed Phase I Clinical Trial Of Pd1-Vaxx, Will Proceed To Third And Final Highest Dose Cohort
- ByReuters-
April 7 (Reuters) - Imugene Ltd IMU.AX :* IMUGENE- COHORT REVIEW COMMITTEE CONFIRMED PHASE I CLINICAL TRIAL OF PD1-VAXX, WILL PROCEED TO THIRD AND FINAL HIGHEST DOSE COHORT